DJIA 17,416.85 225.48 1.31%
NASDAQ 4,683.41 45.41 0.98%
S&P 500 2,021.25 19.09 0.95%
market minute promo


2.77 0.13 (4.92%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VVUS $2.77 4.92%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.82
Previous Close $2.64
Daily Range $2.65 - $2.82
52-Week Range $2.56 - $7.73
Market Cap $287.2M
P/E Ratio -3.72
Dividend (Yield) $0.00 (0.0%)
Volume 2,000,823
Average Daily Volume 2,444,376
Current FY EPS -$0.76





VIVUS, Inc. (VVUS) Description

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products. Website:

News & Commentary Rss Feed

Newly Approved Weight Loss Method Works by Tricking Your Brain

What's the best way to lose weight? One company thinks it's simple: don't get hungry.

Gallup Says Obesity Rates Climb Again - Can Anti-Obesity Companies Cash In?

Contrave Scripts Continue Increases For Orexigen

Arena's Belviq Prescriptions Fall: More Publicity Is Needed

Novo Nordisk Receives Positive Opinion In Europe On Obesity Treatment

Benzinga's Top #PreMarket Gainers

Arena Pharmaceuticals to Raise Fund Via Share Issuance - Analyst Blog

The 52-Week Low Club for Thursday

Vivus (VVUS) Weak On High Volume

Forget Pills! Could This Device Put an End to Obesity in America?

We've witnessed three oral anti-obesity meds approved since mid-2012, but this newly approved device could be a game-changer.

See More VVUS News...

VVUS's Top Competitors

VVUS $2.77 (4.92%)
Current stock: VVUS
NVS $99.16 (2.11%)
Current stock: NVS
PFE $31.83 (-0.38%)
Current stock: PFE
JNJ $102.38 (0.89%)
Current stock: JNJ